Evidence map›Paper›PMID 37214687›Full record

ArticleACS omega2023

Sevde Nur Biltekin, Ayşe Esra Karadağ, Fatih Demirci, Betül Demirci

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Bioactivity ofMolecules (Basel, Switzerland) · 2026
    Article
  5. Histological Evaluation ofBiomedicines · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Nutrients · 2025
    Review
  10. Osage Orange (Pathogens (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Sevde Nur BiltekinDepartment of Pharmaceutical Microbiology, School of Pharmacy, Istanbul Medipol University, 34815 Istanbul, Türkiye.ORCID https://orcid.org/0000-0003-1896-2729
Ayşe Esra KaradağDepartment of Pharmacognosy, İstanbul Medipol University, Faculty of Pharmacy, 34815 İstanbul, Türkiye.ORCID https://orcid.org/0000-0002-3412-0807
Fatih DemirciDepartment of Pharmacognosy, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Türkiye.ORCID https://orcid.org/0000-0003-1497-3017
Betül DemirciDepartment of Pharmacognosy, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Türkiye.
Anadolu University · TRIstanbul Medipol University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spearmint,

Identifiers

PMID37214687
PMCPMC10193545
OpenAlexW4372341969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.